Gilead Sciences and Galapagos present updated results for phase III studies of filgotinib March 29, 2019
Cimzia becomes the first and only FDA-approved treatment for nonradiographic axial spondyloarthritis March 29, 2019
Studies with cordycepin point to polyadenylation as a target for treating osteoarthritis March 20, 2019
IMP-761 inhibits antigen-specific T-cell-mediated immune responses in vitro and in vivo March 20, 2019
Fujian Institute of Research on the Structure of Matter presents interferon modulators March 15, 2019
RSS